Medroxyprogesterone (MPG)

MPA; 17α-Hydroxy-6α-Methylprogesterone Acetate; Provera

Medroxyprogesterone (MPG)
Medroxyprogesterone acetate is a steroidal progestin, a synthetic variant of the human hormone progesterone. It is used as a contraceptive, in hormone replacement therapy and for the treatment of endometriosis as well as several other indications. MPA is a more potent derivative of its parent compound medroxyprogesterone (MP). While medroxyprogesterone is sometimes used as a synonym for medroxyprogesterone acetate, what is normally being administered is MPA and not MP. MPA acts as an agonist of the progesterone, androgen, and glucocorticoid receptors (PR, AR, and GR, respectively), activating these receptors with EC50 values of approximately 0.01 nM, 1 nM, and 10 nM, respectively. It has very low and likely completely insignificant affinity for the estrogen and mineralocorticoid receptors (ER and MR, respectively).

Organism species: Pan-species (General)